Bacterial cell membrane and DNA

The bacterial cell membrane and DNA represent two critical, yet distinct, therapeutic targets in antimicrobial therapy. The bacterial cell membrane is a phospholipid bilayer that maintains cellular integrity, regulates transport, and facilitates energy production through the maintenance of a proton motive force (StatPearls, PMID: 32310518). DNA serves as the repository of genetic information, requiring enzymes like DNA gyrase and topoisomerase IV for replication and transcription (PubMed, PMID: 12654733). Drugs such as polymyxins and daptomycin target the membrane by inducing pore formation or depolarization, leading to the leakage of intracellular contents and rapid cell death (NIH, 2022). Conversely, fluoroquinolones and nitroimidazoles target DNA-related processes, causing double-strand breaks or inhibiting the unwinding of the double helix. While both are essential for bacterial survival, they are structurally and functionally independent, making this a composite target designation rather than a single molecular entity. This multi-target approach is often exploited by certain antimicrobial peptides that first disrupt the membrane to gain entry and then bind to intracellular DNA (Frontiers in Microbiology, 2017). Understanding these targets is vital for developing treatments against multi-drug resistant bacterial infections.

Other names

Bacterial envelope and genomeProkaryotic membrane and DNABacterial cytoplasmic membrane and chromosomal DNA

Disruption of membrane integrity and inhibition of DNA replication and repair